mesalamine has been researched along with Budd-Chiari Syndrome in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Budd-Chiari Syndrome: A condition in which the hepatic venous outflow is obstructed anywhere from the small HEPATIC VEINS to the junction of the INFERIOR VENA CAVA and the RIGHT ATRIUM. Usually the blockage is extrahepatic and caused by blood clots (THROMBUS) or fibrous webs. Parenchymal FIBROSIS is uncommon.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marchetti, F | 1 |
| Mainetti, M | 1 |
| Giovannini, M | 1 |
| Morelli, C | 1 |
1 other study available for mesalamine and Budd-Chiari Syndrome
| Article | Year |
|---|---|
[Budd-Chiari syndrome and ulcerative colitis in an adolescent.]
Topics: Adolescent; Anti-Inflammatory Agents; Anticoagulants; Budd-Chiari Syndrome; Colitis, Ulcerative; Fem | 2017 |